77 related articles for article (PubMed ID: 20055713)
1. Immunomodulatory role of thymulin in lung diseases.
Santos M; Henriques-Coelho T; Leite-Moreira A
Expert Opin Ther Targets; 2010 Feb; 14(2):131-41. PubMed ID: 20055713
[TBL] [Abstract][Full Text] [Related]
2. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
3. Role of thymulin or its analogue as a new analgesic molecule.
Dardenne M; Saade N; Safieh-Garabedian B
Ann N Y Acad Sci; 2006 Nov; 1088():153-63. PubMed ID: 17192563
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory potential of thymulin-Zn(2+) in the alveolar epithelium: amelioration of endotoxin-induced cytokine release and partial amplification of a cytoprotective IL-10-sensitive pathway.
Haddad JJ; Land SC; Saadé NE; Safieh-Garabedian B
Biochem Biophys Res Commun; 2000 Aug; 274(2):500-5. PubMed ID: 10913367
[TBL] [Abstract][Full Text] [Related]
5. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways.
Nasseri B; Zaringhalam J; Daniali S; Manaheji H; Abbasnejad Z; Nazemian V
Int Immunopharmacol; 2019 May; 70():225-234. PubMed ID: 30851702
[TBL] [Abstract][Full Text] [Related]
6. Modulation of inflammatory response in mice with severe autoimmune disease by thymic peptide thymulin and an inhibitor of NF-kappaB signalling.
Lunin SM; Khrenov MO; Novoselova TV; Parfenyuk SB; Glushkova OV; Fesenko EE; Novoselova EG
Int Immunopharmacol; 2015 Apr; 25(2):260-6. PubMed ID: 25662754
[TBL] [Abstract][Full Text] [Related]
7. Inflammation in methotrexate-induced pulmonary toxicity occurs via the p38 MAPK pathway.
Kim YJ; Song M; Ryu JC
Toxicology; 2009 Feb; 256(3):183-90. PubMed ID: 19100307
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
10. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
[TBL] [Abstract][Full Text] [Related]
11. Second-generation inhibitors demonstrate the involvement of p38 mitogen-activated protein kinase in post-transcriptional modulation of inflammatory mediator production in human and rodent airways.
Birrell MA; Wong S; McCluskie K; Catley MC; Hardaker EL; Haj-Yahia S; Belvisi MG
J Pharmacol Exp Ther; 2006 Mar; 316(3):1318-27. PubMed ID: 16368902
[TBL] [Abstract][Full Text] [Related]
12. Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway.
Henriques-Coelho T; Oliveira SM; Moura RS; Roncon-Albuquerque R; Neves AL; Santos M; Nogueira-Silva C; La Fuente Carvalho F; Brandão-Nogueira A; Correia-Pinto J; Leite-Moreira AF
Endocrinology; 2008 Sep; 149(9):4367-73. PubMed ID: 18511508
[TBL] [Abstract][Full Text] [Related]
13. Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.
Leiba M; Cahalon L; Shimoni A; Lider O; Zanin-Zhorov A; Hecht I; Sela U; Vlodavsky I; Nagler A
J Leukoc Biol; 2006 Aug; 80(2):399-406. PubMed ID: 16769768
[TBL] [Abstract][Full Text] [Related]
14. Selective improvement of thymus and some T cell dysfunctions in NZB mice by in utero thymulin treatment.
Quéré P; Dardenne M; Bach MA
J Immunol; 1985 Aug; 135(2):1180-5. PubMed ID: 2409141
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of leaves of Eriobotrya japonica correlating with attenuation of p38 MAPK, ERK, and NF-kappaB activation in mast cells.
Kim SH; Shin TY
Toxicol In Vitro; 2009 Oct; 23(7):1215-9. PubMed ID: 19665545
[TBL] [Abstract][Full Text] [Related]
16. The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer.
Yong HY; Koh MS; Moon A
Expert Opin Investig Drugs; 2009 Dec; 18(12):1893-905. PubMed ID: 19852565
[TBL] [Abstract][Full Text] [Related]
17. Avermectin exerts anti-inflammatory effect by downregulating the nuclear transcription factor kappa-B and mitogen-activated protein kinase activation pathway.
Ci X; Li H; Yu Q; Zhang X; Yu L; Chen N; Song Y; Deng X
Fundam Clin Pharmacol; 2009 Aug; 23(4):449-55. PubMed ID: 19453757
[TBL] [Abstract][Full Text] [Related]
18. Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-kappaB signaling pathway in murine macrophages.
Jung HW; Seo UK; Kim JH; Leem KH; Park YK
J Ethnopharmacol; 2009 Mar; 122(2):313-9. PubMed ID: 19162159
[TBL] [Abstract][Full Text] [Related]
19. Leptospiral membrane proteins stimulate pro-inflammatory chemokines secretion by renal tubule epithelial cells through toll-like receptor 2 and p38 mitogen activated protein kinase.
Hung CC; Chang CT; Tian YC; Wu MS; Yu CC; Pan MJ; Vandewalle A; Yang CW
Nephrol Dial Transplant; 2006 Apr; 21(4):898-910. PubMed ID: 16339163
[TBL] [Abstract][Full Text] [Related]
20. Thymus hormones as prospective anti-inflammatory agents.
Lunin SM; Novoselova EG
Expert Opin Ther Targets; 2010 Aug; 14(8):775-86. PubMed ID: 20536297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
